PROX1 and astrocytoma (excluding glioblastoma): Oligoastrocytomas showed a mean of 17.7%, astrocytomas of 16.5%, gemistocytic astrocytomas of 10.6% and oligodendrogliomas of 12.5% PROX1 immunopositive tumour cells.